1つはDDSをもつ光感受性物質の開発です。薬剤のキャリアにinacti

1つはDDSをもつ光感受性物質の開発です。

薬剤のキャリアにinactivated viral vectorを用いています。
添付の論文1を参考にされてください。



もう1つはTissue Optics的アプローチによるPDT効率の向上です。
PDT後のがん組織の光学特性を測定し、論文として発表しました。
こちらも参考にされてください。

申請書ご執筆のお役に立てれば幸いです。

Results (English) 1:

One is the development of a light sensitive substance with DDS.Drug carriers are using inactivated viral vector.Article 1 of the attachment, is referring to.Another one is the PDT efficiency based on Tissue Optics approach.PDT after cancer was announced as the article, and then measuring the tissue optical properties.Also try being helpful.Submit your writing can help.

Results (English) 2:

One is the development of light-sensitive material with a DDS. The drug of career I am using the inactivated viral vector. Please is a paper 1 of the accompanying reference. And one is to improve PDT efficiency by Tissue Optics approach. To measure the optical properties of the cancer tissue after PDT, was announced as paper. Here Please also be helpful. I am happy if Re help you of application form your writing.

Results (English) 3:

One of the photosensitive material with DDS development. On the carrier of drug using inactivated viral vector. Article 1 with reference to the attached. It is one of the PDT efficiency is improved by Tissue Optics approach. After the measurement of the optical characteristics of the PDT cancer tissue, and published. Get over here. The application of this writing is to be useful. Too